FdaApplication

NDA 020793

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMS
application_typeNDA
approval_date1999-09-21

Products (2)

ProductActive ingredientStrengthDosage form
CAFCITCAFFEINE CITRATEEQ 30MG BASE/3ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION;ORAL
CAFCITCAFFEINE CITRATEEQ 30MG BASE/3ML (EQ 10MG BASE/ML)SOLUTION;INTRAVENOUS

2 products